| Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise (NCT00478972) | Sanofi | 2007-04-01 |
| A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males (NCT00475371) | Mannkind Corporation | 2007-04-01 |
| Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only (NCT00518115) | GlaxoSmithKline | 2007-04-01 |
| The Clinical and Economic Impacts of e-Heath on Diabetes (NCT01595269) | Dr. Danièle Pacaud | 2007-04-01 |
| Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug (NCT00478595) | Sanofi | 2007-04-01 |
| Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects (NCT00478322) | Incyte Corporation | 2007-04-01 |
| A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers (NCT00504816) | GlaxoSmithKline | 2007-04-01 |
| English Diabetes Self-Management Program (NCT00684086) | Stanford University | 2007-04-01 |
| Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus. (NCT00476437) | Novo Nordisk A/S | 2007-04-01 |
| A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin (NCT00468039) | Novartis | 2007-03-06 |
| Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes (NCT00709917) | Novo Nordisk A/S | 2007-03-01 |
| Effect of Pioglitazone on Ambulatory Blood Pressure (NCT00328393) | University of Erlangen-Nürnberg Medical School | 2007-03-01 |
| This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus (NCT00418522) | Pfizer | 2007-03-01 |
| A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes (NCT00449605) | Sanofi | 2007-03-01 |
| Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors (NCT00458081) | Sanofi | 2007-03-01 |
| Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia (NCT00490178) | Solvay Pharmaceuticals | 2007-03-01 |
| A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment. (NCT00437606) | Hoffmann-La Roche | 2007-03-01 |
| Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes (NCT00825253) | Novo Nordisk A/S | 2007-03-01 |
| Assessing Inherited Markers of Metabolic Syndrome in the Young (NCT00966407) | Eric Hoffman | 2007-02-01 |
| Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes (NCT00432809) | The Cleveland Clinic | 2007-02-01 |
| A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks (NCT00427401) | Pfizer | 2007-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes (NCT02211963) | Boehringer Ingelheim | 2007-02-01 |
| A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers (NCT00501397) | GlaxoSmithKline | 2007-02-01 |
| A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin. (NCT00423501) | Hoffmann-La Roche | 2007-02-01 |
| Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI. (NCT00430040) | University at Buffalo | 2007-02-01 |
| Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes (NCT00715663) | Novo Nordisk A/S | 2007-02-01 |
| A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects (NCT00454233) | Astellas Pharma Inc | 2007-02-01 |
| Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity (NCT00454597) | Universidad de Guanajuato | 2007-02-01 |
| BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus (NCT02183324) | Boehringer Ingelheim | 2007-02-01 |
| Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes (NCT00437112) | Eli Lilly and Company | 2007-02-01 |
| Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) (NCT00500331) | GlaxoSmithKline | 2007-01-23 |
| Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes (NCT00427154) | Novo Nordisk A/S | 2007-01-10 |
| GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation (NCT07677865) | West China Hospital | 2007-01-01 |
| A Quality Ensuring Project With Focus On Patients With Cardiovascular Diseases As Well As Type 2 Diabetes. (NCT00415428) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-01-01 |
| Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan (NCT01263470) | Takeda | 2007-01-01 |
| ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects (NCT00437775) | Assaf-Harofeh Medical Center | 2007-01-01 |
| Consultations in Adapted Physical Activity on Behaviours in Physical Exercise by Type 2 Diabetics (NCT00403741) | University Hospital, Grenoble | 2007-01-01 |
| Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus (NCT00425490) | Sheba Medical Center | 2007-01-01 |
| OatMeal and Insulin Resistance: OMA-IR (NCT00401453) | Universitätsmedizin Mannheim | 2007-01-01 |
| Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes (NCT01565733) | Novo Nordisk A/S | 2007-01-01 |
| Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide (NCT00569907) | HealthPartners Institute | 2007-01-01 |
| An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment (NCT00696995) | Novo Nordisk A/S | 2007-01-01 |
| Metformin for the Treatment of Diabetes in Pregnancy (NCT00414245) | Soroka University Medical Center | 2007-01-01 |
| A Study for Patients With Diabetes Mellitus (IOPA) (NCT00420095) | Eli Lilly and Company | 2007-01-01 |
| L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols (NCT04406402) | Tel-Aviv Sourasky Medical Center | 2006-12-05 |
| Insulin Therapy in the Hospital Comparing Two Protocols (NCT00841919) | Cook County Health | 2006-12-01 |
| The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM) (NCT01449019) | Ludwig-Maximilians - University of Munich | 2006-12-01 |
| The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD (NCT00521690) | Novo Nordisk A/S | 2006-12-01 |
| A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® (NCT00391027) | Pfizer | 2006-12-01 |
| Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes (NCT00411892) | Novo Nordisk A/S | 2006-11-29 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes (NCT02212925) | Boehringer Ingelheim | 2006-11-01 |
| Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy (NCT00406458) | Sangamo Therapeutics | 2006-11-01 |
| Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women (NCT01508858) | Novo Nordisk A/S | 2006-11-01 |
| A Study of Aleglitazar in Patients With Type 2 Diabetes (NCT00388518) | Hoffmann-La Roche | 2006-11-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00393718) | Novo Nordisk A/S | 2006-11-01 |
| "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM (NCT00402012) | Pennington Biomedical Research Center | 2006-11-01 |
| Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes (NCT00399711) | Novo Nordisk A/S | 2006-11-01 |
| Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice (NCT01492166) | Novo Nordisk A/S | 2006-11-01 |
| A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers (NCT00501683) | GlaxoSmithKline | 2006-11-01 |
| Lantus Versus Levemir Treat-To-Target (NCT00405418) | Sanofi | 2006-11-01 |
| Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes (NCT00348712) | Novo Nordisk A/S | 2006-10-30 |
| Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers (NCT00394030) | GlaxoSmithKline | 2006-10-16 |
| Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes (NCT00343980) | Novo Nordisk A/S | 2006-10-10 |
| A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin (NCT00386100) | GlaxoSmithKline | 2006-10-01 |
| Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos (NCT01542489) | Novo Nordisk A/S | 2006-10-01 |
| Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes (NCT00389415) | Novartis | 2006-10-01 |
| Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone (NCT00396357) | Novartis Pharmaceuticals | 2006-10-01 |
| Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00395746) | Novo Nordisk A/S | 2006-10-01 |
| Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone (NCT00396227) | Novartis Pharmaceuticals | 2006-10-01 |
| Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes (NCT00401622) | LifeScan | 2006-10-01 |
| Evaluation of Safety and Parameters of Application Technique (NCT01516242) | Novo Nordisk A/S | 2006-10-01 |
| Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus (NCT00391209) | Eli Lilly and Company | 2006-10-01 |
| A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. (NCT00388986) | Hoffmann-La Roche | 2006-10-01 |
| Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) (NCT00393705) | Eli Lilly and Company | 2006-10-01 |
| Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin (NCT00396071) | Novartis Pharmaceuticals | 2006-10-01 |
| Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes (NCT01517555) | Novo Nordisk A/S | 2006-10-01 |
| Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs (NCT00494767) | GlaxoSmithKline | 2006-09-29 |
| Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes (NCT00659282) | Novo Nordisk A/S | 2006-09-11 |
| Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes (NCT00382096) | Novartis Pharmaceuticals | 2006-09-01 |
| Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes (NCT01865305) | Novo Nordisk A/S | 2006-09-01 |
| A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus (NCT00367445) | Pfizer | 2006-09-01 |
| Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes (NCT00390520) | Novartis | 2006-09-01 |
| LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus (NCT00349986) | Sanofi | 2006-09-01 |
| Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00383877) | Novo Nordisk A/S | 2006-09-01 |
| Vascular Reactivity in Kidney Disease Patients (NCT00226902) | Melbourne Health | 2006-09-01 |
| Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes (NCT00383578) | Novartis Pharmaceuticals | 2006-09-01 |
| Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise (NCT00382473) | University of Pittsburgh | 2006-09-01 |
| A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus (NCT00437164) | GlaxoSmithKline | 2006-09-01 |
| Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes (NCT01124656) | Takeda | 2006-09-01 |
| Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes (NCT00331604) | Novo Nordisk A/S | 2006-08-31 |
| To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes (NCT00368134) | Novartis | 2006-08-01 |
| The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction (NCT01542476) | Novo Nordisk A/S | 2006-08-01 |
| Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study (NCT01140542) | AstraZeneca | 2006-08-01 |
| Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR) (NCT00437554) | Handok Inc. | 2006-08-01 |
| A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes. (NCT00377442) | Hoffmann-La Roche | 2006-08-01 |
| Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes (NCT01865292) | Novo Nordisk A/S | 2006-08-01 |
| Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes (NCT00376038) | GlaxoSmithKline | 2006-08-01 |
| Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes (NCT00355849) | Eli Lilly and Company | 2006-08-01 |
| Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX) (NCT00377858) | Eli Lilly and Company | 2006-08-01 |
| Effect of Androgel on Type 2 Diabetic Males With Hypogonadism (NCT00350701) | University at Buffalo | 2006-07-01 |